IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.
about
Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.Epigenetics in the Pathogenesis of Esophageal AdenocarcinomaEndoscopic biopsies from gastrointestinal carcinomas and their suitability for molecular analysis: a review of the literature and recommendations for clinical practice and research.Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry.The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.Modulated DISP3/PTCHD2 expression influences neural stem cell fate decisionsAndrogen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer.A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas
P2860
Q35097641-A548429E-DCD2-4774-991E-8DC0E76224BEQ35237915-C07C552E-9CD6-499A-8704-6FBE46304AECQ35598456-F493EDEA-4ABF-471D-A4FC-81465F876B60Q38272251-7A5EAC06-8FA9-42BE-9EE8-D3A82B5538E2Q38432514-ECB33FB4-7807-452F-8C7D-5C530C0CF6FDQ38586626-DDAF7A4C-47E5-4148-86E0-7A1B04E4C4BBQ38649673-B5629E32-54CA-4B16-A861-C1B887BAAC2DQ38827878-7FEC3901-9A50-4188-88E8-187169B579DCQ40193407-D0589005-8931-4B55-92C6-2148A96CA3B5Q40341808-0A1F89FD-FF18-47DC-B9A7-9DF296C9DAE7Q41693807-144AC567-FCC8-4339-83AE-CABD12F93043Q42084630-334B3EF4-8C3C-4DC0-A24D-86A13773EF3EQ47108270-A577832F-B454-4883-9E2A-904C5A49A2FCQ51525461-1F0BFA79-4CC7-4B64-863B-AA6D1BECB352Q58763391-EED67F77-7E7D-4399-A9DD-39B1FF4262D8
P2860
IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IGFBP7 is associated with poor ...... d by promoter DNA methylation.
@en
IGFBP7 is associated with poor ...... d by promoter DNA methylation.
@nl
type
label
IGFBP7 is associated with poor ...... d by promoter DNA methylation.
@en
IGFBP7 is associated with poor ...... d by promoter DNA methylation.
@nl
prefLabel
IGFBP7 is associated with poor ...... d by promoter DNA methylation.
@en
IGFBP7 is associated with poor ...... d by promoter DNA methylation.
@nl
P2860
P356
P1476
IGFBP7 is associated with poor ...... ed by promoter DNA methylation
@en
P2093
A R Ruszkiewicz
G G Jamieson
P2860
P2888
P304
P356
10.1038/BJC.2013.783
P407
P577
2013-12-19T00:00:00Z